1-6 of 6
Thomas Schober
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gonadal Function in Survivors After Hodgkin Lymphoma (HL) Treatment within the German Hodgkin Study Group (GHSG) HD13–15 Trials.

Karolin Behringer, MD, Horst Mueller, PhD, Helen Goergen, Indra Thielen, MD, Angelika Eibl, Volker Stumpf, Carsten Wessels, Martin Wiehlpuetz, Johannes Rosenbrock, Teresa Halbsguth, MD, Katrin S. Reiners, PhD, Thomas Schober, Joerg H Renno, Michael von Wolff, Katrin van der Ven, Marietta Kuehr, Michael Fuchs, MD, Volker Diehl, MD, Andreas Engert, MD, Peter Borchmann, MD
Journal: Blood
Blood (2012) 120 (21): 2636.
https://doi.org/10.1182/blood.V120.21.2636.2636
Published: 2012
Journal Articles

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Clinical Trials & Observations
Teresa V. Halbsguth, Lucia Nogová, Horst Mueller, Michal Sieniawski, Dennis A. Eichenauer, Thomas Schober, Hiltrud Nisters-Backes, Peter Borchmann, Volker Diehl, Andreas Engert, Andreas Josting
Journal: Blood
Blood (2010) 116 (12): 2026–2032.
https://doi.org/10.1182/blood-2009-11-253211
Published: 2010
Journal Articles

“Quality of Life (QoL) in the Randomised HD10-12 Trials of the German Hodgkin Study Group (GHSG): Sexual Functions (SX) in Hodgkin Lymphoma (HL) Patients Decrease by Disease Stage and Improve After Therapy Depending On Stage and Treatment Modality.”.

Karolin Behringer, Horst Mueller, Hans-Henning Flechtner, Corinne Brillant, Teresa Halbsguth, Thomas Schober, Hiltrud Nisters-Backes, Andreas Engert, MD, Peter Borchmann
Journal: Blood
Blood (2009) 114 (22): 896.
https://doi.org/10.1182/blood.V114.22.896.896
Published: 2009
Journal Articles

The Newly Developed Modified BEACOPP-Regimen (BACOPP) Is Active and Feasible in Elderly Patients with Hodgkin Lymphoma: Results of a Phase II Study of the German Hodgkin Study Group (GHSG)

Horst Mueller, Lucia Nogova, Dennis A Eichenauer, Teresa Halbsguth, Hiltrud Nisters-Backes, Thomas Schober, Hartmut Eimermacher, Peter Borchmann, Michael Fuchs, Andreas Engert, Andreas Josting
Journal: Blood
Blood (2008) 112 (11): 2600.
https://doi.org/10.1182/blood.V112.11.2600.2600
Published: 2008
Journal Articles

Quality of Life in a 2-Year Follow-up: Signs of PNP Predicting Cognitive Functioning in Survivors Treated in the HD10–12 Trials of the German Hodgkin Study Group (GHSG).

Teresa Halbsguth, Horst Mueller, Hans-Henning Flechtner, Corinne Brillant, Karolin Behringer, Thomas Schober, Hiltrud Nisters-Backes, Andreas Engert, Peter Borchmann
Journal: Blood
Blood (2008) 112 (11): 1455.
https://doi.org/10.1182/blood.V112.11.1455.1455
Published: 2008
Journal Articles

Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.

Andreas Josting, MD, Jeremy Franklin, PhD, Michal Sieniawski, MD, Beate Pfistner, PhD, Thomas Schober, Hildtrud Nisters-Backes, Andreas Engert, MD, Volker Diehl, MD
Journal: Blood
Blood (2005) 106 (11): 818.
https://doi.org/10.1182/blood.V106.11.818.818
Published: 2005